Brambell FW, Hemmings WA, Morris IG
The evidence was based on experimental data only briefly described in the patent and included models of: gastric ulcers, heart damage, liver damage, pancreatic injury, kidney damage, experimental diabetes, fever, edema, rhinitis, bone fracture, burns, skin wounds, hypersensitivity reactions, pupil dilation, colon injury, tumour growth, radiation injury, red blood cell development, fertility and lactation, tooth damage, several types of central and peripheral nerve damage, and survival from infection with Trichinosis (i.e., tapeworms) as well as several viruses
Small cellular changes begin to show results over 30 days
most can be stored at room temperature for a limited period after first use per product labeling
Chaque flacon contient : BPC-157 5 mg TB-500 (Squence Complte de la Thymosine 4) 5 mg Ces peptides prsentent des profils de recherche diffrents mais complmentaires
The responsible takeaway is that topical GHK-Cu has a reassuring but not exhaustively proven safety record, while systemic use is genuinely under-studied in humans